(untitled) - Wu, Y L (2020)
CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1–N2 NSCLC with EGFR mutation—final overall survival analysis of the randomized phase III trial 1 analysis of the randomized phase III trial. ASCO Virtual Scientific Program, American Society of Clinical Oncology,